添加剂制造Fe-AZ31生物降解复合材料的生物相容性:用于颅面植入应用
Biocompatibility of Additively Manufactured Fe-AZ31 Biodegradable Composites for Craniofacial Implant Applications
AI总结:
研究评估了添加剂制造Fe-AZ31生物降解复合材料的体内外生物相容性,发现其具有良好的细胞兼容性和组织反应,支持其作为颅面修复的可降解金属植入物的开发。
摘要:
金属镀层系统由钛及其合金组成,仍然是颅面骨固定的标准治疗方式,但可能由于感染、植入物迁移或不适需要二次移除。因此,生物降解金属植入物可能在保持结构完整性的同时消除并发症和二次手术。我们之前的研究所展示的是通过添加剂制造制备了不相容的Fe-AZ31复合材料,其降解动力学优于纯铁。本研究旨在评估Fe-AZ31复合材料的体外和体内生物相容性,以用于潜在的颅面固定应用。纯铁(Fe)、镁合金(AZ31)和Fe-AZ31样品用于基于提取物的细胞毒性测试,使用HFF-1成纤维细胞、L929成纤维细胞和hFOB成骨细胞。金属提取物在37°C的完全培养基中以3 cm²/mL的表面积体积比制备,24小时和72小时暴露后通过活/死测定检测细胞活力。对于体内评估,Fe-AZ31、Fe和Ti板被植入在野生型小鼠皮下,持续6周、3个月和6个月。植入物降解、组织学反应、血象和血清生化指标被评估。Fe-AZ31提取物在所有细胞类型中均显示出超过70%的细胞活力,细胞形态和粘附正常,而AZ31提取物导致显著的细胞毒性,伴随明显的碱化(pH 10)。体内,Fe-AZ31植入物表现出逐渐的表面腐蚀,伴有轻微的、短暂的炎症和最小的囊形成。没有系统毒性被观察到。血象和血清生化指标保持在生理范围内。添加剂制造的Fe-AZ31复合材料显示出可接受的生物相容性和有利的组织反应,支持其作为可降解金属固定装置用于颅面重建的发展。
英文摘要:
Metallic plating systems composed of titanium and its alloys remain the standard treatment for craniofacial bony fixation but may require secondary removal due to infection, implant migration, or discomfort. Thus, biodegradable metallic implants may eliminate complications and secondary procedures while maintaining structural integrity. Our previous work demonstrated the fabrication of immiscible Fe-AZ31 composites via additive manufacturing with improved degradation kinetics over pure Iron. This study aimed to evaluate the in vitro and in vivo biocompatibility of Fe-AZ31 composites for potential craniofacial fixation applications. Pure iron (Fe), Mg alloy (AZ31) and Fe-AZ31 samples were fabricated for extract-based cytotoxicity testing using HFF-1 fibroblasts, L929 fibroblasts and hFOB osteoblasts. Metal extracts were prepared at a 3 cm^2/mL surface-to-volume ratio in complete media at 37C and cell viability was measured by live/dead assay after 24 and 72h exposure. For in vivo evaluation, Fe-AZ31, Fe, and Ti plates were implanted subcutaneously in wild type mice for 6 weeks, 3 and 6 months. Implant degradation, histologic response, hematology, and serum biochemistry were assessed. Fe-AZ31 extracts demonstrated >70% cell viability across all cell types at both timepoints with normal cell morphology and adhesion, whereas AZ31 extracts caused marked cytotoxicity associated with pronounced alkalization (pH 10). In vivo, Fe-AZ31 implants exhibited gradual surface corrosion accompanied by mild, transient inflammation and minimal capsule formation over time. No systemic toxicity was observed. Hematology and serum biochemistry remained within physiological limits. Additively manufactured Fe-AZ31 composites demonstrate acceptable biocompatibility and favorable tissue responses, supporting their development as resorbable metallic fixation devices for craniofacial reconstruction.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。